All In Biotech

Free tool

FAERS Monitor: Reglan

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 017854 or its brand name (Reglan, Metoclopramide Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

77,180

Serious

69,461

90% of reports

Hospitalization

34,338

Death reported

9,975

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • tardive dyskinesia16,216
  • extrapyramidal disorder12,921
  • nervous system disorder7,526
  • dystonia7,115
  • nausea6,547
  • pain5,998
  • vomiting4,989
  • diarrhoea4,164
  • anxiety4,091
  • economic problem3,962
  • incorrect drug administration duration3,710
  • fatigue3,614
  • dyspnoea3,307
  • movement disorder3,272
  • dyskinesia3,214

Reports by year received

View as table
YearReports
20041,145
20051,207
20061,167
20071,134
20081,315
20091,732
20102,835
201112,666
20127,303
20132,666
20142,319
20152,550
20162,948
20172,755
20183,701
20194,071
20203,888
20214,264
20224,266
20233,846
20243,498
20253,286
20262,601

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,976,979 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
tardive dyskinesiaSignal16,216366.5358.42,520,252
extrapyramidal disorderSignal12,921294.2287.31,815,039
dystoniaSignal7,115157.2152.8700,241
economic problemSignal3,96296.192.7275,491
nervous system disorderSignal7,52686.384.2482,217
incorrect drug administration durationSignal3,71041.239.9126,636
movement disorderSignal3,27230.829.784,853
dyskinesiaSignal3,21423.322.563,321
anxietySignal4,0914.03.89,041
vomitingSignal4,9892.92.86,336
painSignal5,9982.72.66,427
nauseaSignal6,5472.32.24,764
diarrhoea4,1641.81.71,408
dyspnoea3,3071.61.5750
fatigue3,6141.31.2209

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.